Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents
暂无分享,去创建一个
G. Breithardt | P. Teirstein | A. J. O’Malley | J. Moses | M. Leon | E. Orav | L. Mauri | D. Holmes | D. Kereiakes | D. Cutlip | J. Schofer | B. Firth | R. Kuntz | C. Shi | Dennis J. Donohoe | A. J. O’Malley
[1] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[2] J. Moses,et al. Quantitative Assessment of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Native Coronary Arteries , 2004, Circulation.
[3] Ameet Bakhai,et al. Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial , 2004, Circulation.
[4] P. Serruys,et al. CORONARY ARTERY DISEASE Original Studies Clinical Outcomes for Sirolimus-Eluting Stent Implantation and Vascular Brachytherapy for the Treatment of In-Stent Restenosis , 2004 .
[5] Patrick W Serruys,et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. , 2004, Journal of the American College of Cardiology.
[6] W. O’Neill,et al. Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy , 2004, Circulation.
[7] Antonio Colombo,et al. Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.
[8] Patrick W Serruys,et al. Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin-E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry , 2004, Circulation.
[9] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[10] William Wijns,et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.
[11] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[12] M. Leon,et al. Usefulness of a cobalt chromium coronary stent alloy. , 2003, The American journal of cardiology.
[13] Samin K. Sharma,et al. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). , 2003, American heart journal.
[14] Muzaffer Degertekin,et al. TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation , 2003, Circulation.
[15] S. Normand,et al. Application of models for multivariate mixed outcomes to medical device trials: coronary artery stenting , 2002, Statistics in medicine.
[16] A. Kastrati,et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.
[17] D. Baim,et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. , 2002, Journal of the American College of Cardiology.
[18] L. Mauri,et al. Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. , 2002, The American journal of cardiology.
[19] Ousa,et al. A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .
[20] A. Kastrati,et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. , 2003, Journal of the American College of Cardiology.
[21] D. Baim,et al. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. , 2001, The American journal of cardiology.
[22] M. Leon,et al. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. , 2001, The American journal of cardiology.
[23] Larry S. Dean,et al. Randomized Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenoses , 2000, Circulation.
[24] P. Boekstegers,et al. Influence of stent design on 1‐year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[25] C. Di Mario,et al. Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: The Milan Dose-Response Study. , 2000, Circulation.
[26] Samin K. Sharma,et al. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) , 1998, Circulation.
[27] B. D. de Smet,et al. Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. , 1997, Circulation.
[28] H Yokoi,et al. Three-year follow-up after implantation of metallic coronary-artery stents. , 1996, The New England journal of medicine.
[29] W Rutsch,et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.
[30] P. Teirstein,et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.
[31] D. Baim,et al. Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant? , 1994, The American journal of cardiology.
[32] J. Reiber,et al. A new approach for the quantification of complex lesion morphology: the gradient field transform; basic principles and validation results. , 1994, Journal of the American College of Cardiology.
[33] D. Baim,et al. Defining coronary restenosis. Newer clinical and angiographic paradigms. , 1993, Circulation.
[34] D. Baim,et al. Mechanisms of restenosis and redilation within coronary stents--quantitative angiographic assessment. , 1993, Journal of the American College of Cardiology.
[35] C M Gibson,et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. , 1993, Journal of the American College of Cardiology.
[36] D. Baim,et al. Novel approach to the analysis of restenosis after the use of three new coronary devices. , 1992, Journal of the American College of Cardiology.
[37] P. Serruys,et al. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. , 1992, Journal of the American College of Cardiology.
[38] E J Topol,et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. , 1990, Circulation.
[39] F. Loop,et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Circulation.